Synthetic cell preservation strategies enable their storage and activation at the point of use.

Abstract read

In one paragraph

Article in Chemical communications (Cambridge, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Synthetic cells for phage therapy: a perspective.Frontiers in cellular and infection microbiology · 2025
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ignacio GispertDepartment of Chemical Engineering, Imperial College London, South Kensington, London SW7 2AZ, UK.ORCID http://orcid.org/0000-0002-4100-5225

Yuval ElaniDepartment of Chemical Engineering, Imperial College London, South Kensington, London SW7 2AZ, UK.ORCID http://orcid.org/0000-0002-9603-2490

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthetic cells encapsulating cell-free protein synthesis machinery are currently limited to laboratory use due to preservation challenges. They are typically produced and used immediately. We present drying methods for long-term ambient storage that preserve their integrity and functionality, enabling activation at the point-of-use, overcoming key barriers to their deployment in biotechnology.

Indexed as

Artificial CellsCell-Free System

Identifiers

PMID40357556

DOI10.1039/d5cc00826c

PMCPMC12070246

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.